Robert Gross, MD, MSCE
Professor of Medicine (Infectious Diseases)
Department: Medicine
Contact information
804 Blockley Hall
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-898-2437
Fax: 215-573-5315
Fax: 215-573-5315
Publications
Education:
BA (Italian)
Cornell University , 1986.
MD
Cornell University, 1991.
MSCE (Pharmacoepidemiology)
University of Pennsylvania, 2000.
BA (Italian)
Cornell University , 1986.
MD
Cornell University, 1991.
MSCE (Pharmacoepidemiology)
University of Pennsylvania, 2000.
Links
Search PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Permanent linkSearch PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Selected Publications
Pickel J, Fiks AG, Karavite D, Maleki P, Beidas RS, Dowshen N, Petsis D, Gross R, Wood S : Provider perspectives on clinical decision support to improve HIV prevention in pediatric primary care: A multiple methods study Implementation Science Communications 2023 (in press).Golder S, Medaglio D, O’Connor K, Gross R, Hennessy S, Gonzalez Hernandez G: Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors. JAMA Network Open 2023 (in press).
Motlokwa PK, Tsima BM, Gross R: Prior Treatment For Tuberculosis Associated With Salivary Gland Dysfunction In People With HIV. International Journal of Oral and Dental Health 2023 (in press).
Medaglio D, Bilker WB, Han X, Merlin JS, Plankey M, Martin J, Crane HM, Hojat LS, Bamford L, Schnoll R, Tyndale RF, *Ashare RL, *Gross R (*equal work by authors): Nicotine Metabolite Ratio Decreases after Switching off Efavirenz-based Therapy in People with HIV who Smoke. Clinical Pharmacology and Therapeutics 2023 (in press).
Van Pelt A, Bilker WB, Nkwihorez H, Ghadimi F, Brady KA, Cidav Z, Schriger S, Beidas RS, Gross R, Momplaisir F,: Increasing anti-retroviral therapy adherence and retention in care among adults living with HIV in Philadelphia: A study protocol for a stepped-wedge cluster-randomized type 2 hybrid effectiveness-implementation trial of Managed Problem Solving Plus (MAPS+) delivered by community health workers. BMJ Open 2023 (in press).
Mannathoko N, Mosepele M, Gross R, Smith R, Styczynski A, Cressman L, Richard-Greenblatt M, Glaser L, Alby K, Jaskowiak-Barr A, Sewawa K, Cowden L, Otukile D, Paganotti GM, Mokomane M, Bilker WB, Lautenbach E: Risk Factors for Community Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clinical Infectious Diseases 2023 (in press).
Tsima BM, Opondo P, Mosepele M, Mautle E, Bilker WB, Gross R: Prevalence of the metabolic syndrome and associated factors among inpatients with severe mental illness in Botswana: a cross-sectional study. BMC Cardiovascular Disorders 2022 (in press).
Cioe PA, Schnoll R, Hoeppner BB, Gross R, Hitsman BL, Leone FT, Ashare R, Vilardaga R, Tashima K, Pinkston M, Kahler CW: The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV who Smoke. AIDS and Behavior 2022 (in press).
Mannathoko N, Mosepele M, Gross R, Smith R, Alby K, Glaser L,Richard-Greenblatt M, Sharma A,Jaskowiak-Barr A, Cressman L, Sewawa K, Cowden L, Reesey E, Otukile D, Paganotti G, Mokomane M, Lautenbach E : Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study International Journal of Infectious Diseases 2022 (in press).
Arens Y, Bilker WB, Han X, Plankey M, Ware D, Friedman MR, D’Souza G, Stosor V, Shoptaw S, Schnoll RA, Tyndale RF, Ashare R*, Gross R* *equal contribution by authors: HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living with HIV. JAIDS 2022 (in press).